INDIVIOR PLC (INDV) Stock Fundamental Analysis
NASDAQ:INDV - Nasdaq - GB00BN4HT335 - Common Stock - Currency: USD
INDV gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 193 industry peers in the Pharmaceuticals industry. INDV has an average financial health and profitability rating. INDV has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
INDV had negative earnings in the past year.
In the past year INDV had a positive cash flow from operations.
In multiple years INDV reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: INDV reported negative operating cash flow in multiple years.
1.2 Ratios
INDV's Return On Assets of -4.00% is fine compared to the rest of the industry. INDV outperforms 77.20% of its industry peers.
INDV has a better Return On Invested Capital (111.88%) than 100.00% of its industry peers.
INDV had an Average Return On Invested Capital over the past 3 years of 43.06%. This is significantly above the industry average of 14.87%.
The 3 year average ROIC (43.06%) for INDV is below the current ROIC(111.88%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4% | ||
| ROE | N/A | ||
| ROIC | 111.88% |
ROA(3y)-3.2%
ROA(5y)-1.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)43.06%
ROIC(5y)30.49%
1.3 Margins
In the last couple of years the Profit Margin of INDV has declined.
INDV has a better Operating Margin (25.44%) than 91.19% of its industry peers.
In the last couple of years the Operating Margin of INDV has remained more or less at the same level.
INDV's Gross Margin of 83.98% is amongst the best of the industry. INDV outperforms 89.12% of its industry peers.
INDV's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 25.44% | ||
| PM (TTM) | N/A | ||
| GM | 83.98% |
OM growth 3Y-2.47%
OM growth 5Y-1.25%
PM growth 3Y-81.34%
PM growth 5Y-60.3%
GM growth 3Y0.52%
GM growth 5Y0.74%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), INDV is creating value.
The number of shares outstanding for INDV has been reduced compared to 1 year ago.
Compared to 5 years ago, INDV has less shares outstanding
The debt/assets ratio for INDV is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.93 indicates that INDV is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.93, INDV is in the better half of the industry, outperforming 73.06% of the companies in the same industry.
The Debt to FCF ratio of INDV is 2.49, which is a good value as it means it would take INDV, 2.49 years of fcf income to pay off all of its debts.
INDV has a better Debt to FCF ratio (2.49) than 92.75% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.49 | ||
| Altman-Z | 2.93 |
ROIC/WACC10.83
WACC10.33%
2.3 Liquidity
INDV has a Current Ratio of 0.88. This is a bad value and indicates that INDV is not financially healthy enough and could expect problems in meeting its short term obligations.
INDV's Current ratio of 0.88 is on the low side compared to the rest of the industry. INDV is outperformed by 87.05% of its industry peers.
A Quick Ratio of 0.72 indicates that INDV may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.72, INDV is doing worse than 85.49% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.88 | ||
| Quick Ratio | 0.72 |
3. Growth
3.1 Past
The earnings per share for INDV have decreased strongly by -1736.71% in the last year.
Measured over the past years, INDV shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -55.78% on average per year.
Looking at the last year, INDV shows a very strong growth in Revenue. The Revenue has grown by 83.27%.
The Revenue has been growing by 8.64% on average over the past years. This is quite good.
EPS 1Y (TTM)-1736.71%
EPS 3Y-77.57%
EPS 5Y-55.78%
EPS Q2Q%10.81%
Revenue 1Y (TTM)83.27%
Revenue growth 3Y14.52%
Revenue growth 5Y8.64%
Sales Q2Q%-6.34%
3.2 Future
Based on estimates for the next years, INDV will show a small growth in Earnings Per Share. The EPS will grow by 5.66% on average per year.
The Revenue is expected to grow by 2.59% on average over the next years.
EPS Next Y-20.5%
EPS Next 2Y-3.84%
EPS Next 3Y2.76%
EPS Next 5Y5.66%
Revenue Next Year-8.41%
Revenue Next 2Y-2.87%
Revenue Next 3Y-0.2%
Revenue Next 5Y2.59%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
INDV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 10.09 indicates a reasonable valuation of INDV.
INDV's Price/Forward Earnings ratio is rather cheap when compared to the industry. INDV is cheaper than 83.42% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 35.34. INDV is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 10.09 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, INDV is valued cheaper than 98.96% of the companies in the same industry.
INDV's Price/Free Cash Flow ratio is rather cheap when compared to the industry. INDV is cheaper than 87.56% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.54 | ||
| EV/EBITDA | 3.41 |
4.3 Compensation for Growth
INDV has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.84%
EPS Next 3Y2.76%
5. Dividend
5.1 Amount
No dividends for INDV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
15.38
-0.24 (-1.54%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners86.46%
Inst Owner Change0%
Ins Owners3.78%
Ins Owner ChangeN/A
Market Cap1.92B
Analysts82.5
Price Target15.62 (1.56%)
Short Float %6.58%
Short Ratio5.2
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.6%
PT rev (3m)3.04%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.95%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 10.09 | ||
| P/S | 0.93 | ||
| P/FCF | 14.54 | ||
| P/OCF | 11.56 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 3.41 |
EPS(TTM)-0.38
EYN/A
EPS(NY)1.52
Fwd EY9.91%
FCF(TTM)1.06
FCFY6.88%
OCF(TTM)1.33
OCFY8.65%
SpS16.51
BVpS-2.28
TBVpS-2.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4% | ||
| ROE | N/A | ||
| ROCE | 141.62% | ||
| ROIC | 111.88% | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 25.44% | ||
| PM (TTM) | N/A | ||
| GM | 83.98% | ||
| FCFM | 6.41% |
ROA(3y)-3.2%
ROA(5y)-1.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)43.06%
ROIC(5y)30.49%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)54.5%
ROCE(5y)38.6%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.47%
OM growth 5Y-1.25%
PM growth 3Y-81.34%
PM growth 5Y-60.3%
GM growth 3Y0.52%
GM growth 5Y0.74%
F-Score5
Asset Turnover1.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.49 | ||
| Debt/EBITDA | 0.57 | ||
| Cap/Depr | 136% | ||
| Cap/Sales | 1.65% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 30.24% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.88 | ||
| Quick Ratio | 0.72 | ||
| Altman-Z | 2.93 |
F-Score5
WACC10.33%
ROIC/WACC10.83
Cap/Depr(3y)163.83%
Cap/Depr(5y)132.28%
Cap/Sales(3y)2.67%
Cap/Sales(5y)2.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1736.71%
EPS 3Y-77.57%
EPS 5Y-55.78%
EPS Q2Q%10.81%
EPS Next Y-20.5%
EPS Next 2Y-3.84%
EPS Next 3Y2.76%
EPS Next 5Y5.66%
Revenue 1Y (TTM)83.27%
Revenue growth 3Y14.52%
Revenue growth 5Y8.64%
Sales Q2Q%-6.34%
Revenue Next Year-8.41%
Revenue Next 2Y-2.87%
Revenue Next 3Y-0.2%
Revenue Next 5Y2.59%
EBIT growth 1Y103.89%
EBIT growth 3Y11.69%
EBIT growth 5Y7.28%
EBIT Next Year13.79%
EBIT Next 3Y10.08%
EBIT Next 5Y12.03%
FCF growth 1Y473.91%
FCF growth 3Y-74.97%
FCF growth 5Y-48.94%
OCF growth 1Y374.29%
OCF growth 3Y-53.28%
OCF growth 5Y-24.93%